Clinical Trial Update: Efficacy and Safety Study of ME-609 and Acyclovir for Treatment of Herpes Simplex Labialis [Phase 3]

View source ↗

Summary

Phase 3 trial comparing ME-609 to acyclovir for treatment of herpes labialis has completed; final results are not provided in the snippet.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Herpes Labialis

Drugs mentioned

• ACYCLOVIR (Acyclovir)
• ME-609

Snippet

Sponsor: Medivir | Conditions: Herpes Labialis | Phase 3 | Status: COMPLETED